FREQ Frequency Therapeutics, Inc.

Frequency Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of small molecule drugs that activate progenitor cells within the body to restore healthy tissue. The company was founded by Robert S. Langer, Jr., David L. Lucchino, Christopher Loose and Will J. McLean in November 13, 2014 and is headquartered in Woburn, MA.

As of 11/30/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/03/2019
Outstanding shares:  34,602,285
Average volume:  181,411
Market cap:   $194,810,865
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    35803L108
ISIN:        US35803L1089
Valuation   (See tab for details)
PE ratio:   -2.51
PB ratio:   1.25
PS ratio:   8.11
Return on equity:   -49.90%
Net income %:   -305.79%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy